CNS Neuroprotection edited by Frank W. Marcoux, Dennis W. Choi.

"CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human n...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Marcoux, Frank W. (Editor), Choi, Dennis W. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2002.
Edition:1st ed. 2002.
Series:Handbook of Experimental Pharmacology, 155
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Section I: Mechanic Approaches to CNS Neuroprotection
  • 1 Blocking Excitotoxicity
  • 2 Limiting Apoptosis as a Strategy for CNS Neuroprotection
  • 3 Reducing Neuroinflammation
  • 4 Mitochondrial Approaches to Neuroprotection
  • 5 Stabilizing Calcium Homeostasis
  • 6 Blocking Nitric Oxide Toxicity
  • Section II: Neuroprotective Agents
  • 7 Adenosine-Based Approaches to the Treatment of Neurodegenerative Disease
  • 8 Sodium and Calcium Channel Blockers
  • 9 Neuroprotection by Free Radical Scavengers and Other Antioxidants
  • 10 Chemokines and Chemokine Receptors in the Central Nervous System: New Opportunities for Novel Therapeutics in Brain Ischemia and Trauma
  • Section III: CNS Delivery of Neuroprotective Therapies
  • 11 Ex Vivo Gene Therapy in the Central Nervous System
  • 12 Developing Gene-Based Neuroprotection Strategies Using Herpes Amplicon Vectors
  • Section IV: Disease Targetily of Newoportective Therapies
  • 13 Stroke
  • 14 Traumatic Central Nervous System Injury
  • 15 Neurohormonal Signalling Pathways and the Regulation of Alzheimer ?-amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer’s Disease
  • 16 Amyotrophic Lateral Sclerosis
  • 17 Therapeutics in Huntington’s Disease.